Royalty Pharma plc (NASDAQ:RPRX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 11, 2025 Royalty Pharma plc misses on earnings expectations. Reported EPS is ...
Cytokinetics stock touches 52-week low at $41.69 amid market challenges
In a turbulent market environment, Cytokinetics , Incorporated (NASDAQ:CYTK) stock has reached its 52-week low, trading at $41.69, with a sharp 14% decline just last week. According to InvestingPro ...
Next phase of Kilroy's big Oyster Point project sees interest beyond biotech
The next phase of Kilroy's big Oyster Point project is seeing interest from tech and financial services as well as biotech, ...